Surgery Partners, Inc. (SGRY) Just Recorded A Sigfniciant Increase

December 7, 2017 - By Marie Mckinney

The stock of Surgery Partners, Inc. (NASDAQ:SGRY) is a huge mover today! The stock increased 5.99% or $0.5 during the last trading session, reaching $8.85. About 418,984 shares traded. Surgery Partners, Inc. (NASDAQ:SGRY) has risen 53.68% since December 7, 2016 and is uptrending. It has outperformed by 36.98% the S&P500.
The move comes after 8 months positive chart setup for the $431.61M company. It was reported on Dec, 7 by Barchart.com. We have $9.65 PT which if reached, will make NASDAQ:SGRY worth $38.84 million more.

Analysts await Surgery Partners, Inc. (NASDAQ:SGRY) to report earnings on March, 8. They expect $0.13 earnings per share, down 31.58 % or $0.06 from last year’s $0.19 per share. SGRY’s profit will be $6.34M for 17.02 P/E if the $0.13 EPS becomes a reality. After $-0.04 actual earnings per share reported by Surgery Partners, Inc. for the previous quarter, Wall Street now forecasts -425.00 % EPS growth.

Surgery Partners, Inc. (NASDAQ:SGRY) Ratings Coverage

Among 10 analysts covering Surgery Partners (NASDAQ:SGRY), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Surgery Partners had 29 analyst reports since October 26, 2015 according to SRatingsIntel. KeyBanc Capital Markets downgraded the stock to “Sector Weight” rating in Wednesday, August 9 report. KeyBanc Capital Markets initiated Surgery Partners, Inc. (NASDAQ:SGRY) rating on Friday, June 10. KeyBanc Capital Markets has “Overweight” rating and $21 target. The stock has “Neutral” rating by Bank of America on Wednesday, November 1. The company was initiated on Monday, October 26 by Bank of America. As per Friday, August 11, the company rating was maintained by Citigroup. The company was downgraded on Friday, March 10 by Stifel Nicolaus. RBC Capital Markets maintained Surgery Partners, Inc. (NASDAQ:SGRY) on Monday, June 12 with “Buy” rating. The rating was maintained by Stifel Nicolaus on Wednesday, June 21 with “Hold”. As per Wednesday, August 9, the company rating was downgraded by Raymond James. The firm earned “Buy” rating on Monday, March 14 by Citigroup.

More notable recent Surgery Partners, Inc. (NASDAQ:SGRY) news were published by: Seekingalpha.com which released: “Surgery Partners’ (SGRY) Management on Q3 2017 Results – Earnings Call Transcript” on November 09, 2017, also Globenewswire.com with their article: “Surgery Partners, Inc. Announces Third Quarter 2017 Results” published on November 08, 2017, Forbes.com published: “Surgery Partners Stock Plummets After Q2 Results Hint At Integration Challenges” on August 10, 2017. More interesting news about Surgery Partners, Inc. (NASDAQ:SGRY) were released by: Prnewswire.com and their article: “Scott+Scott, Attorneys at Law, LLP Announces Investigation into Surgery …” published on December 07, 2017 as well as Seekingalpha.com‘s news article titled: “Surgery Partners’ (SGRY) CEO Brett Roberts on Q2 2017 Results – Earnings Call …” with publication date: August 09, 2017.

Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company has market cap of $431.61 million. The firm operates through three divisions: Surgical Facility Services, Ancillary Services, and Optical Services. It currently has negative earnings. The Company’s surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastrointestinal, general surgery, ophthalmology, orthopedics, and pain management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.